Breaking the barriers in management of Alzheimer's disease through cationic nanoformulation: A review
Neurodegenerative Alzheimer's disease (AD) leads to cognitive and behavioral decline. The current crop of FDA-approved treatments for AD can only reduce symptoms and postpone the disease's progression by facilitating communication between neurons in brain of AD patient. Any potential treat...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Results in Chemistry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715624001590 |